Identifying In-Trans Process Associated Genes in Breast Cancer by Integrated Analysis of Copy Number and Expression Data

PLoS ONE

Volumn 8, Issue 1, 2013, Pages

  Aure, Miriam Ragle ^a,b   Steinfeld, Israel ^c   Baumbusch, Lars Oliver ^a   Liestøl, Knut ^b   Lipson, Doron ^c   Nyberg, Sandra ^a,b   Naume, Bjørn ^a   Sahlberg, Kristine Kleivi ^a,b   Kristensen, Vessela N ^a,b,d   Børresen Dale, Anne Lise ^a,b   Lingjærde, Ole Christian ^b   Yakhini, Zohar ^c,e  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

^c TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

^d AKERSHUS UNIVERSITY HOSPITAL   (Norway)

^e Agilent Laboratories   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

SMALL INTERFERING RNA;

ARTICLE; ATPASE FAMILY AAA DOMAIN CONTAINING GENE; BREAST CARCINOMA; CHROMOSOME ABERRATION; CONTROLLED STUDY; COPY NUMBER VARIATION; EPITHELIAL CELL TRANSFORMING SEQUENCE 2 ONCOGENE; ERBB2 GENE; GENE; GENE DOSAGE; GENE EXPRESSION; GENE IDENTIFICATION; GENE SILENCING; GENETIC ANALYSIS; GENETIC ASSOCIATION; HUMAN; IN CIS CORRELATED GENE; IN TRANS PROCESS ASSOCIATED AND CIS CORRELATED GENE; MAJOR CLINICAL STUDY; NUCLEOTIDE SEQUENCE; ONCOGENE; PRIMARY TUMOR; RAD21 HOMOLOG GENE; RECQ PROTEIN LIKE 4 GENE;

BREAST NEOPLASMS; CHROMOSOME ABERRATIONS; COMPARATIVE GENOMIC HYBRIDIZATION; DNA COPY NUMBER VARIATIONS; FEMALE; GENE DOSAGE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENOME, HUMAN; HUMANS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS;

EID: 84873859243     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0053014     Document Type: Article

References (66)

1. Hanahan D, Weinberg RA, (2000) The Hallmarks of Cancer. Cell 100: 57-70.
2. Hanahan D, Weinberg Robert A, (2011) Hallmarks of Cancer: The Next Generation. Cell 144: 646-674.
3. Russnes HG, Vollan HKM, Lingjærde OC, Krasnitz A, Lundin P, et al. (2010) Genomic Architecture Characterizes Tumor Progression Paths and Fate in Breast Cancer Patients. Science Translational Medicine 2: 38ra47.
4. Inaki K, Hillmer AM, Ukil L, Yao F, Woo XY, et al. (2011) Transcriptional consequences of genomic structural aberrations in breast cancer. Genome Research 21: 676-687.
5. Hyman E, Kauraniemi Pi, Hautaniemi S, Wolf M, Mousses S, et al. (2002) Impact of DNA Amplification on Gene Expression Patterns in Breast Cancer. Cancer Research 62: 6240-6245.
6. Bergamaschi A, Kim YH, Wang P, Sørlie T, Hernandez-Boussard T, et al. (2006) Distinct patterns of DNA copy number alteration are associated with different clinicopathological features and gene-expression subtypes of breast cancer. Genes, Chromosomes and Cancer 45: 1033-1040.
7. Fridlyand J, Snijders A, Ylstra B, Li H, Olshen A, et al. (2006) Breast tumor copy number aberration phenotypes and genomic instability. BMC Cancer 6: 96.
8. Naylor TL, Greshock J, Wang Y, Colligon T, Yu QC, et al. (2005) High resolution genomic analysis of sporadic breast cancer using array-based comparative genomic hybridization. Breast Cancer Res 7: R1186-R1198.
9. Pollack JR, Perou CM, Alizadeh AA, Eisen MB, Pergamenschikov A, et al. (1999) Genome-wide analysis of DNA copy-number changes using cDNA microarrays. Nat Genet 23: 41-46.
10. Pollack JR, Sørlie T, Perou CM, Rees CA, Jeffrey SS, et al. (2002) Microarray analysis reveals a major direct role of DNA copy number alteration in the transcriptional program of human breast tumors. Proceedings of the National Academy of Sciences 99: 12963-12968.
11. Curtis C, Shah SP, Chin S-F, Turashvili G, Rueda OM, et al. (2012) The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups. Nature 486: 346-352.
12. Dehan E, Ben-Dor A, Liao W, Lipson D, Frimer H, et al. (2007) Chromosomal aberrations and gene expression profiles in non-small cell lung cancer. Lung Cancer 56: 175-184.
13. Goh XY, Rees JRE, Paterson AL, Chin SF, Marioni JC, et al. (2011) Integrative analysis of array-comparative genomic hybridisation and matched gene expression profiling data reveals novel genes with prognostic significance in oesophageal adenocarcinoma. Gut.
14. Taylor BS, Schultz N, Hieronymus H, Gopalan A, Xiao Y, et al. (2010) Integrative Genomic Profiling of Human Prostate Cancer. Cancer Cell 18: 11-22.
15. Parris TZ, Danielsson A, Nemes S, Kovács A, Delle U, et al. (2010) Clinical Implications of Gene Dosage and Gene Expression Patterns in Diploid Breast Carcinoma. Clinical Cancer Research 16: 3860-3874.
16. Creixell P, Schoof EM, Erler JT, Linding R, (2012) Navigating cancer network attractors for tumor-specific therapy. Nat Biotech 30: 842-848.
17. Akavia UD, Litvin O, Kim J, Sanchez-Garcia F, Kotliar D, et al. (2010) An Integrated Approach to Uncover Drivers of Cancer. Cell 143: 1005-1017.
18. Chari R, Coe B, Vucic E, Lockwood W, Lam W, (2010) An integrative multi-dimensional genetic and epigenetic strategy to identify aberrant genes and pathways in cancer. BMC Systems Biology 4: 67.
19. Natrajan R, Weigelt B, Mackay A, Geyer F, Grigoriadis A, et al. (2010) An integrative genomic and transcriptomic analysis reveals molecular pathways and networks regulated by copy number aberrations in basal-like, HER2 and luminal cancers. Breast Cancer Research and Treatment 121: 575-589.
20. Xu C, Liu Y, Wang P, Fan W, Rue T, et al. (2010) Integrative analysis of DNA copy number and gene expression in metastatic oral squamous cell carcinoma identifies genes associated with poor survival. Molecular Cancer 9: 143.
21. Cho Y-J, Tsherniak A, Tamayo P, Santagata S, Ligon A, et al. (2011) Integrative Genomic Analysis of Medulloblastoma Identifies a Molecular Subgroup That Drives Poor Clinical Outcome. Journal of Clinical Oncology 29: 1424-1430.
22. Kim H, Huang W, Jiang X, Pennicooke B, Park PJ, et al. (2010) Integrative genome analysis reveals an oncomir/oncogene cluster regulating glioblastoma survivorship. Proceedings of the National Academy of Sciences 107: 2183-2188.
23. Woo HG, Park ES, Lee J-S, Lee Y-H, Ishikawa T, et al. (2009) Identification of Potential Driver Genes in Human Liver Carcinoma by Genomewide Screening. Cancer Research 69: 4059-4066.
24. Naume B, Borgen E, Kvalheim G, Kåresen R, Qvist H, et al. (2001) Detection of Isolated Tumor Cells in Bone Marrow in Early-Stage Breast Carcinoma Patients. Clinical Cancer Research 7: 4122-4129.
25. Kristensen VN, Vaske CJ, Ursini-Siegel J, Van Loo P, Nordgard SH, et al. (2011) Integrated molecular profiles of invasive breast tumors and ductal carcinoma in situ (DCIS) reveal differential vascular and interleukin signaling. Proceedings of the National Academy of Sciences.
26. Enerly E, Steinfeld I, Kleivi K, Leivonen S-K, Aure MR, et al. (2011) miRNA-mRNA Integrated Analysis Reveals Roles for miRNAs in Primary Breast Tumors. PLoS ONE 6: e16915.
27. Wiedswang G, Borgen E, Kåresen R, Kvalheim G, Nesland JM, et al. (2003) Detection of Isolated Tumor Cells in Bone Marrow Is an Independent Prognostic Factor in Breast Cancer. Journal of Clinical Oncology 21: 3469-3478.
28. Sorlie T, Wang Y, Xiao C, Johnsen H, Naume B, et al. (2006) Distinct molecular mechanisms underlying clinically relevant subtypes of breast cancer: gene expression analyses across three different platforms. BMC Genomics 7: 127.
29. Naume B, Zhao X, Synnestvedt M, Borgen E, Russnes HG, et al. (2007) Presence of bone marrow micrometastasis is associated with different recurrence risk within molecular subtypes of breast cancer. Molecular oncology 1: 160-171.
30. Nordgard SH, Johansen FE, Alnæs GIG, Bucher E, Syvänen A-C, et al. (2008) Genome-wide analysis identifies 16q deletion associated with survival, molecular subtypes, mRNA expression, and germline haplotypes in breast cancer patients. Genes, Chromosomes and Cancer 47: 680-696.
31. Weigman V, Chao H-H, Shabalin A, He X, Parker J, et al. (2011) Basal-like Breast cancer DNA copy number losses identify genes involved in genomic instability, response to therapy, and patient survival. Breast Cancer Research and Treatment: 1-16.
32. Lingjærde OC, Baumbusch LO, Liestøl K, Glad IK, Børresen-Dale A-L, (2005) CGH-Explorer: a program for analysis of array-CGH data. Bioinformatics 21: 821-822.
33. Baumbusch LO, Aaroe J, Johansen FE, Hicks J, Sun H, et al. (2008) Comparison of the Agilent, ROMA/NimbleGen and Illumina platforms for classification of copy number alterations in human breast tumors. BMC Genomics 9: 379.
34. Nilsen G, Liestøl K, Van Loo P, Vollan HKM, Eide MB, et al. (2012) Copynumber: Efficient algorithms for single- and multi-track copy number segmentation. BMC Genomics 13: 591.
35. Lipson D, Ben-Dor A, Dehan E, Yakhini Z (2004) Joint analysis of DNA copy numbers and gene expression levels. Proceedings of Workshop on Algorithms in Bioinformatics (WABI) in Bergen, Norway.
36. Lipson D, Aumann Y, Ben-Dor A, Linial N, Yakhini Z, (2006) Efficient calculation of interval scores for DNA copy number data analysis. J Comput Biol 13: 215-228.
37. Ashburner M, Ball CA, Blake JA, Botstein D, Butler H, et al. (2000) Gene Ontology: tool for the unification of biology. Nat Genet 25: 25-29.
38. Eden E, Lipson D, Yogev S, Yakhini Z, (2007) Discovering Motifs in Ranked Lists of DNA Sequences. PLoS Comput Biol 3: e39.
39. Eden E, Navon R, Steinfeld I, Lipson D, Yakhini Z, (2009) GOrilla: a tool for discovery and visualization of enriched GO terms in ranked gene lists. BMC Bioinformatics 10: 48.
40. Ciró M, Prosperini E, Quarto M, Grazini U, Walfridsson J, et al. (2009) ATAD2 Is a Novel Cofactor for MYC, Overexpressed and Amplified in Aggressive Tumors. Cancer Research 69: 8491-8498.
41. Shehata M, Bièche I, Boutros R, Weidenhofer J, Fanayan S, et al. (2008) Nonredundant Functions for Tumor Protein D52-Like Proteins Support Specific Targeting of TPD52. Clinical Cancer Research 14: 5050-5060.
42. Balleine RL, Fejzo MS, Sathasivam P, Basset P, Clarke CL, et al. (2000) The hD52 (TPD52) gene is a candidate target gene for events resulting in increased 8q21 copy number in human breast carcinoma. Genes, Chromosomes and Cancer 29: 48-57.
43. Choschzick M, Lassen P, Lebeau A, Marx AH, Terracciano L, et al. (2010) Amplification of 8q21 in breast cancer is independent of MYC and associated with poor patient outcome. Mod Pathol 23: 603-610.
44. Byrne JA, Balleine RL, Fejzo MS, Mercieca J, Chiew Y-E, et al. (2005) Tumor protein D52 (TPD52) is overexpressed and a gene amplification target in ovarian cancer. International Journal of Cancer 117: 1049-1054.
45. Lu X, Ma O, Nguyen T-A, Jones SN, Oren M, et al. (2007) The Wip1 Phosphatase Acts as a Gatekeeper in the p53-Mdm2 Autoregulatory Loop. Cancer Cell 12: 342-354.
46. Fujimoto H, Onishi N, Kato N, Takekawa M, Xu XZ, et al. (2005) Regulation of the antioncogenic Chk2 kinase by the oncogenic Wip1 phosphatase. Cell Death Differ 13: 1170-1180.
47. Lambros MB, Natrajan R, Geyer FC, Lopez-Garcia MA, Dedes KJ,et al. PPM1D gene amplification and overexpression in breast cancer: a qRT-PCR and chromogenic in situ hybridization study. Mod Pathol 23: 1334-1345.
48. Dahl E, Kristiansen G, Gottlob K, Klaman I, Ebner E, et al. (2006) Molecular Profiling of Laser-Microdissected Matched Tumor and Normal Breast Tissue Identifies Karyopherin Alpha2 as a Potential Novel Prognostic Marker in Breast Cancer. Clinical Cancer Research 12: 3950-3960.
49. Wang Y, Klijn JGM, Zhang Y, Sieuwerts AM, Look MP, et al. (2005) Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer. The Lancet 365: 671-679.
50. Sotiriou C, Wirapati P, Loi S, Harris A, Fox S, et al. (2006) Gene Expression Profiling in Breast Cancer: Understanding the Molecular Basis of Histologic Grade To Improve Prognosis. Journal of the National Cancer Institute 98: 262-272.
51. Olesen C, Møller M, Byskov AG, (2004) Tesmin transcription is regulated differently during male and female meiosis. Molecular Reproduction and Development 67: 116-126.
52. Gomulkiewicz A, Podhorska-Okolow M, Szulc R, Smorag Z, Wojnar A,et al. Correlation between metallothionein (MT) expression and selected prognostic factors in ductal breast cancers. Folia Histochemica et Cytobiologica 48: 242-248.
53. Kim HG, Kim JY, Han EH, Hwang YP, Choi JH,et al. Metallothionein-2A overexpression increases the expression of matrix metalloproteinase-9 and invasion of breast cancer cells. FEBS letters 585: 421-428.
54. Cherian MG, Jayasurya A, Bay B-H, (2003) Metallothioneins in human tumors and potential roles in carcinogenesis. Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis 533: 201-209.
55. Ostrakhovitch EA, Olsson P-E, Jiang S, Cherian MG, (2006) Interaction of metallothionein with tumor suppressor p53 protein. FEBS letters 580: 1235-1238.
56. Ostrakhovitch EA, Olsson P-E, von Hofsten J, Cherian MG, (2007) P53 mediated regulation of metallothionein transcription in breast cancer cells. Journal of Cellular Biochemistry 102: 1571-1583.
57. Matsuura T, Kawasaki Y, Miwa K, Sutou S, Ohinata Y, et al. (2002) Germ cell-specific nucleocytoplasmic shuttling protein, tesmin, responsive to heavy metal stress in mouse testes. Journal of Inorganic Biochemistry 88: 183-191.
58. Tatsumoto T, Xie X, Blumenthal R, Okamoto I, Miki T, (1999) Human Ect2 Is an Exchange Factor for Rho Gtpases, Phosphorylated in G2/M Phases, and Involved in Cytokinesis. The Journal of Cell Biology 147: 921-928.
59. Namba R, Maglione JE, Young LJT, Borowsky AD, Cardiff RD, et al. (2004) Molecular Characterization of the Transition to Malignancy in a Genetically Engineered Mouse-Based Model of Ductal Carcinoma In situ. Molecular Cancer Research 2: 453-463.
60. Justilien V, Fields AP, (2009) Ect2 links the PKC[iota]-Par6[alpha] complex to Rac1 activation and cellular transformation. Oncogene 28: 3597-3607.
61. Jung Y, Lee S, Choi H-S, Kim S-N, Lee E, et al. (2011) Clinical Validation of Colorectal Cancer Biomarkers Identified from Bioinformatics Analysis of Public Expression Data. Clinical Cancer Research 17: 700-709.
62. Atienza JM, Roth RB, Rosette C, Smylie KJ, Kammerer S, et al. (2005) Suppression of RAD21 gene expression decreases cell growth and enhances cytotoxicity of etoposide and bleomycin in human breast cancer cells. Molecular Cancer Therapeutics 4: 361-368.
63. Peters J-M, Tedeschi A, Schmitz J, (2008) The cohesin complex and its roles in chromosome biology. Genes & Development 22: 3089-3114.
64. Birkenbihl RP, Subramani S, (1992) Cloning and characterization of rad21 an essential gene of Schizosaccharomyces pombe involved in DNA double-strand-break repair. Nucleic Acids Research 20: 6605-6611.
65. Xu H, Yan M, Patra J, Natrajan R, Yan Y, et al. (2011) Enhanced RAD21 cohesin expression confers poor prognosis and resistance to chemotherapy in high grade luminal, basal and HER2 breast cancers. Breast Cancer Research 13: R9.
66. Shamir R, Maron-Katz A, Tanay A, Linhart C, Steinfeld I, et al. (2005) EXPANDER - an integrative program suite for microarray data analysis. BMC Bioinformatics 6.